Does using hormonal therapy after risk reducing salpingo-oophorectomy increase the incidence of malignancy in women with high risk genetic predisposition to cancer?

Autor:	Laura Kent, K.A. Mills, Premal H. Thaker, Alexis N. Hokenstad, David E. Cohn, Leigha Senter, James C. Cripe, Michelle Kuznicki, Robert M. Wenham, Jamie N. Bakkum-Gamez, Candice Woolfolk, Tanvi V. Joshi
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty business.industry Incidence (epidemiology) Obstetrics and Gynecology Cancer medicine.disease Malignancy Internal medicine medicine Genetic predisposition Hormonal therapy business
Zdroj:	Gynecologic Oncology. 154:168-169
ISSN:	0090-8258
DOI:	10.1016/j.ygyno.2019.04.394
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f6d5201ccb8f9dba0e44c74d309a0fe4 https://doi.org/10.1016/j.ygyno.2019.04.394 Zobrazit plný text záznamu Full Text from ScienceDirect